Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, ...

Welcome back on the Daily Aviation for a new documentary video about the QF-16, a standard F-16 Fighting Falcon modified into ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Creative Biolabs recently rolled out a three-dimensional upgrade designed to make antibodies safer, more potent, and easier to develop. SHIRLEY, NY, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Democrat tells RFK Jr.: ‘You lied to Sen. Cassidy’ Newsom v. Trump judge orders L.A. troop deployment records handed over ...

iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody. New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates (NHP) and ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...